Physician profile
Sherry Li
NPI 1427633601
$967.43
in general payments reported to CMS, 2019-2025
11 companies · $279 in 2025
The $279 reported for 2025 was more than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $348 · 2024: $340 · 2025: $279.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $967.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $967.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $441.06 | 2023-2025 | Impella |
| Astrazeneca Pharmaceuticals LP | $179.38 | 2024-2025 | Airsupra, Fasenra |
| E.R. Squibb & Sons, L.L.C. | $162.97 | 2023 | Camzyos |
| Abbott Laboratories | $39.34 | 2023-2024 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit |
| Chiesi USA, INC. | $29.42 | 2025 | Kengreal |
| Takeda Pharmaceuticals U.S.A., INC. | $23.55 | 2024 | Glassia |
| Merck Sharp & Dohme LLC | $23.50 | 2023 | Verquvo |
| Angiodynamics, INC. | $23.43 | 2025 | Alphavac |
| Bridgebio Pharma, INC. | $22.44 | 2025 | Attruby |
| Optinose US, INC. | $15.78 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $6.56 | 2024 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sherry Li listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.